Cavapoo

Cavapoo
Other namesCavoodle
OriginAustralia
Foundation stockCavalier King Charles Spaniel, Poodle
Breed statusNot recognized as a breed by any major kennel club.
Traits
Height 23–33 cm (9.1–13.0 in)
Weight 4–10 kg (8.8–22.0 lb)
Coat Silky or curled double coat
Dog (domestic dog)

The Cavapoo (American English) or Cavoodle (Australian English) is a crossbreed of a Cavalier King Charles Spaniel and a Poodle. The cavapoo is speculated to have been first bred by designer dog breeders in Australia in the 1950s[1] as a companion dog with similar traits to the cockapoo, but at a smaller size.[2]

Cavapoos can come in many colors including white, golden, brown, and black, often with a contrasting, white tuft on their chests.[1] They can even be tricolored in the vein of Calico cats. The Cavapoo is known for being some being hypoallergenic, as they are part Poodle. This, however, is a misconception. Studies has shown that no breed is truly hypoallergenic but simply less likely to cause a reaction.[3][4] They are very energetic around humans and even cats. They are said to be a great choice for a family, and to be very intelligent and trainable. Less desirable traits such as an urge to assert dominance upon other dogs and issues with potty training have been reported.

See also

References

  1. ^ a b "Dog Breeds: Cavapoo". www.purina.co.uk. Purina. Retrieved 26 June 2024.
  2. ^ Hale (2008), p. 204.
  3. ^ Nicholas, Charlotte E.; Wegienka, Ganesa R.; Havstad, Suzanne L.; Zoratti, Edward M.; Ownby, Dennis R.; Johnson, Christine Cole (July 2011). "Dog Allergen Levels in Homes with Hypoallergenic Compared with Nonhypoallergenic Dogs". American Journal of Rhinology & Allergy. 25 (4): 252–256. doi:10.2500/ajra.2011.25.3606. ISSN 1945-8924. PMC 3680143. PMID 21819763.
  4. ^ Vredegoor, Doris W.; Willemse, Ton; Chapman, Martin D.; Heederik, Dick J.J.; Krop, Esmeralda J.M. (October 2012). "Can f 1 levels in hair and homes of different dog breeds: Lack of evidence to describe any dog breed as hypoallergenic". Journal of Allergy and Clinical Immunology. 130 (4): 904–909.e7. doi:10.1016/j.jaci.2012.05.013. hdl:1874/259846. ISSN 0091-6749. PMID 22728082.

Sources